|

NX-1607 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cbl-b Inhibitor

Pipeline

Phase 1: 1

Top Sponsors

  • Nurix Therapeutics, Inc.1

Indications

  • Richter Transformation1
  • Malignant Pleural Mesothelioma (MPM)1
  • Metastatic or Unresectable Melanoma1
  • Ovarian Cancer, Epithelial1
  • Metastatic Castration-resistant Prostate Cancer, mCRPC1

Duarte, California1 trial

A Study of NX-1607 in Adults With Advanced Malignancies

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.